News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

John Theurer Cancer Center Announces Positive Results With New Targeted Biological In Indolent Non-Hodgkin Lymphoma


1/23/2014 9:13:19 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HACKENSACK, N.J.--(BUSINESS WIRE)--Andre Goy, M.D., Chairman and Director of John Theurer Cancer Center, Chief of the Lymphoma Program and Chief Science Officer and Director of Research and Innovation for Regional Cancer Care Associates, announced today positive results from a phase II study of patients with indolent non-Hodgkin lymphoma (iNHL) published in the New England Journal of Medicine (NEJM). The trial was conducted by Dr. Goy and a number of researchers and physicians from leading institutions around the world.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES